Natixis Advisors LLC Buys 937 Shares of Teleflex Incorporated (NYSE:TFX)

Natixis Advisors LLC lifted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,916 shares of the medical technology company’s stock after purchasing an additional 937 shares during the period. Natixis Advisors LLC’s holdings in Teleflex were worth $5,173,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. Oregon Public Employees Retirement Fund raised its holdings in shares of Teleflex by 1.2% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 4,021 shares of the medical technology company’s stock worth $846,000 after purchasing an additional 46 shares during the period. Cromwell Holdings LLC raised its holdings in shares of Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 49 shares during the period. Crossmark Global Holdings Inc. raised its holdings in shares of Teleflex by 1.9% in the 2nd quarter. Crossmark Global Holdings Inc. now owns 2,779 shares of the medical technology company’s stock worth $584,000 after purchasing an additional 53 shares during the period. Apollon Wealth Management LLC raised its holdings in shares of Teleflex by 3.7% in the 3rd quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after purchasing an additional 55 shares during the period. Finally, SRS Capital Advisors Inc. raised its holdings in shares of Teleflex by 0.3% in the 2nd quarter. SRS Capital Advisors Inc. now owns 19,527 shares of the medical technology company’s stock worth $4,107,000 after purchasing an additional 62 shares during the period. Institutional investors own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Royal Bank of Canada lowered their price target on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Wednesday. Mizuho reduced their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Stephens lifted their price objective on shares of Teleflex from $275.00 to $290.00 and gave the company an “overweight” rating in a research note on Friday, August 2nd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Friday, November 1st. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Teleflex presently has a consensus rating of “Moderate Buy” and an average price target of $259.25.

Teleflex Trading Up 0.6 %

Teleflex stock opened at $191.71 on Friday. The stock has a market cap of $8.90 billion, a P/E ratio of 37.87, a PEG ratio of 1.98 and a beta of 1.18. Teleflex Incorporated has a fifty-two week low of $185.66 and a fifty-two week high of $257.85. The firm’s fifty day moving average price is $226.07 and its 200-day moving average price is $222.79. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.38 by $0.11. The firm had revenue of $764.40 million for the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business’s quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.64 earnings per share. Equities research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.71%. Teleflex’s dividend payout ratio is presently 27.04%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.